Stocktoria

OS Therapies Inc OSTX

NYSE · stock · Pharmaceutical Preparations · website · IPO 2024-08-01

OS Therapies Inc statistics & valuation

Market cap$99.8M

Market cap as of 2026-06-30. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
202320242025
Operating margin (%)
202320242025
Return on equity (%)
202320242025
Shares outstanding
5.4M 20.9M 37.1M 202320242025
Net debt ($)
202320242025
Share buybacks ($)
202320242025
Return on assets (%)
-976.30% -160.40% -420.40% 202320242025
Free cash flow margin (%)
202320242025
Debt / equity (×)
202320242025
EPS ($)
-$1.46 -$1.28 -$0.98 202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023
Return on assets-420.4%-160.4%-976.3%
Return on equity471.7%271.9%32.4%
Current ratio0.031.200.03

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.